secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001437749-25-013232
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

BARDA lifts stop work order on Vaxart norovirus trial; 10,000-participant screening to resume
--------------------------------------------------------------------------------

- Stop work order lifted April 24, 2025 by ATI/BARDA; company may resume incurring costs.
- Virtual meeting with BARDA confirmed Vaxart can proceed with screening 10,000 participants.
- Company intends to reactivate field sites and screen participants for enrollment.
- Discussions with BARDA ongoing regarding dosing plan, costs, timelines, and regulatory pathway.
- Previously all work except per-protocol follow-up for 400-person cohort had been halted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774925013232/0001437749-25-013232-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774925013232/vxrt20250426_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-013232

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer